author-photo

Robert Popovian

Pfizer

14

Papers

877

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Waiving COVID-19 vaccine patents: A bad idea and a dangerous precedent

2021 Journal of Commercial Biotechnology
Show All
- Source
- Cite
- Save
Citations (0)
An Estimate of the Net Benefits from Prior Authorization Policies in the U.S.

2021 Health science journal
- Robert Popovian
- Wayne Winegarden
Show All
- Source
- Cite
- Save
Citations (0)
Sowing confusion in the field: the interchangeable use of biosimilar terminology

2019 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (5)
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (21)
Drug tendering: drug supply and shortage implications for the uptake of biosimilars

2017 ClinicoEconomics and Outcomes Research
Show All
- Source
- Cite
- Save
Citations (27)
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis

2017 PharmacoEconomics
Show All
- Source
- Cite
- Save
Citations (25)
Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

2016 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (115)
Treatment cost of acute exacerbations of chronic bronchitis

1999 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (150)
The cost of treating community-acquired pneumonia

1998 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (506)